Ipopema Benefit 3 Fizan (WSE:IPOBENE3S) - Stock Price, News & Analysis

IPOBENE3S Stock Overview

No business description

No updates

No updates

	IPOBENE3S	PL Capital Markets	PL Market
7D	0%	2.7%	3.3%
1Y	8.9%	16.9%	27.4%

Return vs Industry: IPOBENE3S underperformed the Polish Capital Markets industry which returned 34.8% over the past year.

Return vs Market: IPOBENE3S underperformed the Polish Market which returned 24% over the past year.

Is IPOBENE3S's price volatile compared to industry and market?
IPOBENE3S volatility
IPOBENE3S Average Weekly Movement	n/a
Capital Markets Industry Average Movement	5.9%
Market Average Movement	5.3%
10% most volatile stocks in PL Market	10.0%
10% least volatile stocks in PL Market	3.5%

Stable Share Price: Insufficient data to determine IPOBENE3S's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine IPOBENE3S's volatility change over the past year.

Founded	Employees	CEO	Website
n/a	n/a	n/a

How do Ipopema Benefit 3 Fizan's earnings and revenue compare to its market cap?
IPOBENE3S fundamental statistics
Market Cap	n/a
Earnings (TTM)	zł0
Revenue (TTM)	n/a

P/E Ratio

P/S Ratio

Is IPOBENE3S overvalued?

Key profitability statistics from the latest earnings report
IPOBENE3S income statement (TTM)
Revenue	zł0
Cost of Revenue	zł0
Gross Profit	zł0
Other Expenses	zł0
Earnings	zł0

Last Reported Earnings

n/a

Next Earnings Date

n/a

How did IPOBENE3S perform over the long term?